Fereshteh Ghadiri1, Zahra Ebadi1, Elnaz Asadollahzadeh1

  • 1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

PubMed
概括

伊朗专家对多发性硬化症 (MS) 患者的手术咨询意见达成的协议非常差. 这凸显了管理多发性硬化症疾病修饰疗法 (DMT) 和这些个体的术后风险的挑战.